Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications

Area of Science:

• Endocrinology and Metabolism
• Cellular Biology
• Pathology

Background:

• Global prevalence of diabetes mellitus (DM) and its irreversible complications are increasing.
• Current clinical practice often addresses DM complications in isolation, potentially overlooking interconnected pathways.
• Early detection and systematic management are crucial for improving patient care and outcomes.

Purpose of the Study:

• To explore shared pathological signaling mechanisms among diverse DM complications.
• To identify common early cellular responses across different DM-related pathologies.
• To propose a unified therapeutic strategy for managing multiple DM complications concurrently.

Main Methods:

• Review of current literature on DM pathophysiology and cellular responses.
• Analysis of shared signaling pathways implicated in vascular, immune, glial, and fibroblast cells.
• Identification of potential common early molecular events in DM complications.

Main Results:

• Commonly targeted cell types in DM complications may share early, similar responses to hyperglycemia.
• Interactions between different DM complications can influence their individual progression and severity.
• Shared signaling pathways offer potential targets for simultaneous intervention.

Conclusions:

• Focusing on shared early cellular responses and signaling mechanisms can lead to comprehensive treatment strategies for DM complications.
• Simultaneous treatment of multiple DM complications can improve patient outcomes and minimize adverse effects.
• Further basic and clinical research is needed to validate these shared mechanisms and develop integrated therapeutic approaches.